VivoPower International Announces Board Approval of Share

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
69
VivoPower International Announces Board Approval of Share Repurchase Program and Appointment of Carl Weatherley-White as Chief Financial Officer
  • Authorization to purchase up to $10 million of shares over two years

LONDON, Feb. 23, 2017 (GLOBE NEWSWIRE) -- VivoPower International PLC (“VivoPower” or the “Company”) (NASDAQ: VVPR ), a global next generation solar power company, today announced that its board of directors has authorized the Company to purchase up to $10 million of the Company’s ordinary shares, or approximately 15% of its outstanding ordinary shares, over the next two years. The repurchase program is subject to the Company’s receipt of shareholder approval at a general meeting of shareholders to be held in March 2017.  The Company expects to post notice of this general meeting to shareholders within the next week. 

Under the program, shares may be purchased in open market transactions, including through block purchases, through privately negotiated transactions, or pursuant to any trading plan (a “10b5-1 Plan”) that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the “Exchange Act”). A 10b5-1 Plan allows a company to repurchase its shares at times when it otherwise might be prevented from doing so under the securities laws or because of self-imposed trading blackout periods. The Company expects to enter into a 10b5-1 Plan with Oppenheimer & Co., Inc. (“Oppenheimer”) pursuant to which Oppenheimer will be authorized on the Company’s behalf to purchase the Company’s ordinary shares. Because the repurchases under the 10b5-1 Plan will be subject to pricing parameters, there is no guarantee as to the exact number of shares that will be repurchased pursuant thereto, or that there will be any repurchases pursuant to the plan.

The timing, manner, price and amount of any repurchases will be determined in the Company’s discretion and the share repurchase program may be suspended, terminated or modified at any time for any reason. The repurchase program does not obligate the Company to acquire any specific number of shares, and all open market repurchases will be made in accordance with Exchange Act Rule 10b-18, which sets certain restrictions on the method, timing, price and volume of open market share repurchases.  

The Company also announced the appointment of Carl Weatherley-White as the Company’s Chief Financial Officer. Mr. Weatherley-White, formerly the Company’s Group Finance Director, replaces David Pilotte, who is retiring but will continue with the Company during a transition period.

About VivoPower

VivoPower is a global next generation solar power company that operates a build, transfer and operate (BTO) model to establish an installed solar power asset base in a capital efficient manner. VivoPower does this by aggregating photovoltaic (PV) solar projects underpinned by long term power purchasing agreements and then arranges corporate and project financing, engineering design and equipment procurement and manages the construction and development of such solar PV projects for asset owners. VivoPower intends to leverage this asset base to sell distributed generation power, and manage and provide power support services (encompassing operations, maintenance and optimization) and data driven energy services for commercial, industrial and government customers, pursuant to long term contracts with the asset owners so as to maximize the performance and value of their solar assets.

Forward-Looking Statements

This communication includes certain statements that may constitute “forward-looking statements” for purposes of the U.S. federal securities laws.  Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions.  The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.  Forward-looking statements may include, for example, statements about the benefits of the transactions described in this communication and plans to make future repurchases of VivoPower’s ordinary shares, including the amount of shares that may be repurchased. These statements are based on VivoPower’s managements’ current expectations or beliefs and are subject to risk, uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower’s business. These risks uncertainties and contingencies include business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, general economic conditions, geopolitical events and regulatory changes and other factors set forth in VivoPower’s filings with the Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise.

Contact: Carl Weatherley-White Chief Financial Officer shareholders@vivopower.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 45

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 156

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 198

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 223

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 288

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 116

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 339

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 135

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 89

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors React to Economic Signals Amidst Stock Market Euphoria

Updated Category News Views 189

Understanding Current Market Dynamics In recent discussions surrounding economic trends, investors are facing a pivotal moment. Ruchir Sharma has pointed out a significant shift in investor sentiment that may unravel in the near future. As he suggests, there could be a critical demand for higher interest rates or a demonstration of fiscal responsibility, triggering...

Continue Reading
Canada Goose Faces Investigation Over Tariff Windfall

Updated Category News Views 69

Unpacking the Canada Goose Controversy The luxury outerwear brand Canada Goose is currently weathering a storm of scrutiny tied to how it handled tariffs during a particularly convoluted spell in trade policy. Law firm Edelson Lechtzin LLP has zeroed in on allegations that the company inflated its American pricing to cover tariff costs, never lowering those prices or...

Continue Reading
Teamsters Urge Senators to Support Essential Safety Legislation

Updated Category News Views 212

Teamsters Call for Senate Support on Critical Safety Legislation Bipartisan Legislation Critical to Protecting Good Jobs, Safe Streets Following its advancement from the Colorado State Senate Transportation & Energy Committee, Teamsters are urging lawmakers to rally behind HB 25-1122. This crucial legislation mandates that a trained and licensed human safety operator be...

Continue Reading
Cushman & Wakefield Reinforces Financial Strategy with Loan Repricing

Updated Category News Views 93

Cushman & Wakefield Completes Successful Term Loan Repricing Cushman & Wakefield (NYSE: CWK) has recently announced a significant financial move aimed at optimizing its debt structure. The global commercial real estate services firm successfully completed a repricing of approximately $990 million of its Term Loan, which was issued in January 2023 and is due in 2030. This...

Continue Reading
Celebrating China's 75-Year Transformation in Development

Updated Category News Views 177

China's Remarkable Journey Over 75 Years On October 1, 2024, a significant milestone was celebrated—the 75th anniversary of the People's Republic of China (PRC). This event marks not just a passage of time but highlights a transformative journey that the nation has undertaken since its founding. Over these decades, China has evolved profoundly, emerging from its...

Continue Reading